HHSE Stock | News | Quote | Stock Forum | Monday, November 18,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$HHSE Hannover House, Inc. HHSE Company Overview 

Hannover House, Inc. HHSE Current Price and Quotes
Last Price 0.0144
Previous Close 0.0129 Open 0.012
Daily Range 0.0144 - 0.012 52wk Range 0.0332 - 0.0018
Volume 797,000 Dividend N/A
Average Vol (3m) 750,362 Yield N/A

HHSE Stock Message Board http://investorshangout.com/search?q=HHSE&...mp;yt1=Go!

Last Updated: Monday, November 18, 2013 01:41:30 AM

Hannover House, Inc. HHSE

Company Updated Profile
Company Information

1428 Chester Street
Springdale, AR 72764

Website: http://www.hannoverhouse.com
Phone: 479-751-4500
Email: Fred@HannoverHouse.com
Find us on:  

Hannover House, Inc. HHSE
Hannover House, Inc. is the owner of entertainment media distributor Truman Press, Inc., d/b/a "Hannover House," a well-known and respected publisher of books and distributor of film and video properties, established in 1993 and operating continuously since. Hannover House has a library of over 200 properties, with more than 80 titles in current release to the book, DVD, television or international markets. The company's senior executives are proven top professionals in the film distribution an...



Hannover House, Inc. HHSE
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Aug 15, 2005
Audited Financials Unaudited
Latest Report Sep 30, 2013 Quarterly Report
CIK 0001069680
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 2731 - Book publishing
Incorporated In: WY, USA
Year of Inc. 1993
Employees 6 a/o Jun 30, 2013
Company Officers/Contacts

Eric Parkinson CEO
Fred Shefte President
Company Directors

Eric Parkinson Chairman
Company Notes

Formerly=Target Development Group, Inc. until 4-2012
Formerly=VOIP 5000, Inc. until 4-07
Formerly=DeGreko, Inc. until 6-06
Note=12-05 State of Incorporation Nevada changed to Delaware concurrent with name change
Formerly=Mindset Interactive Corp. until 12-05
Note=3-01 State of Incorporation Texas changed to Nevada concurrent with name change
Formerly=Ecklan Corp. until 3-01
Service Providers

Auditor/Accountant
Hogan Taylor LLP
688 East Millsap
Suite 203
Fayetteville, AR, 72703
United States

Legal Counsel
The Kester Law Firm
P.O. Box 184
Fayetteville, AR, 72702
United States

Investor Relations Firm
Not Available

Hannover House, Inc. HHSE
HHSE Security Details

Share Structure

Market Value1 $7,279,358 a/o Nov 15, 2013
Shares Outstanding 505,510,986 a/o Mar 31, 2013
Float 373,787,474 a/o Jan 01, 2013
Authorized Shares 600,000,000 a/o Jan 28, 2013
Par Value  0.001
Shareholders

Shareholders of Record 171 a/o Jan 01, 2013
Security Notes

Capital Change=shs increased by 1.9 for 1 split. Ex-date=01/29/2001. Rec date=01/26/2001. Pay date=01/29/2001.
Stk. Div.=20%. Ex-date=3-22-06. Rec date=3-24-06. Pay date=3-31-06
Capital Change=shs decreased by 1 for 50 split. Pay date=10/10/2006.
Short Selling Data

Short Interest 1,700 (-84.94%)
Oct 31, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Standard Registrar and Transfer Co., Inc.

Hannover House, Inc. HHSE Financials
HHSE


Hannover House, Inc. HHSE Recent News

Sep 26, 2013 Hannover House Pacts with VUDU for V.O.D. Release of 40 Titles
Aug 20, 2013 Academy Award Winner Octavia Spencer Shines in “Blues for Willadean” from Hannover House


HHSE Hannover House, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=HHSE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/HHSE/quote
Stock Chart http://www.otcmarkets.com/stock/HHSE/chart
Company Info http://www.otcmarkets.com/stock/HHSE/company-info
Recent News http://www.otcmarkets.com/stock/HHSE/news
Financials http://www.otcmarkets.com/stock/HHSE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/HHSE/filings
Short Sales http://www.otcmarkets.com/stock/HHSE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/HHSE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/HHSE/research
Summary http://finance.yahoo.com/q?s=HHSE
Historical Prices http://finance.yahoo.com/q/hp?s=HHSE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=HHSE
Basic Chart http://finance.yahoo.com/q/bc?s=HHSE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HHSE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=HHSE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=HHSE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=HHSE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=HHSE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=HHSE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=HHSE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=HHSE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=HHSE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=HHSE
Balance Sheet http://finance.yahoo.com/q/bs?s=HHSE
Cash Flow http://finance.yahoo.com/q/cf?s=HHSE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/HHSE
Market Watch http://www.marketwatch.com/investing/stock/HHSE
Bloomberg http://www.bloomberg.com/quote/HHSE:US
Morningstar http://quotes.morningstar.com/stock/s?t=HHSE
Bussinessweek http://investing.businessweek.com/research/st...icker=HHSE
Barchart http://www.barchart.com/quotes/stocks/HHSE
OTC Short Report http://otcshortreport.com/index.php?index=HHSE
Investopedia http://www.investopedia.com/markets/stocks/HHSE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles